文献速递心胸血管麻醉

平衡四淀粉原料来源对围术期失血的影响:随机双盲对照试验

Impact of balanced tetrastarch raw material on perioperative blood loss: a randomized double blind controlled trial.
PubMed 文献 · Br J Anaesth · 2016-10-17

该前瞻性随机双盲对照试验将118例择期体外循环心脏手术患者分为玉米来源和马铃薯来源的6%羟乙基淀粉(HES)130/0.40或130/0.42两组,围术期使用目标导向算法给药至术后第二天。主要结局为术后至POD#2的计算失血量,两组无显著差异(504 ml vs 530 ml,P=0.107),次要结局急性肾损伤(AKI)发生率及长期肾功能也无显著差异。

要点

  • 玉米与马铃薯来源的四淀粉在心脏手术围术期失血量上无显著差异。
  • 两种来源HES的AKI发生率及长期肾功能影响相似。
  • HES原料来源不影响围术期血液成分输注需求。

核心结论

  • 在本研究条件下,HES 130/0.4或130/0.42的原料来源对围术期失血无显著影响,且未发现四淀粉原料组成对短期和长期肾功能有影响。

研究设计与样本

  • 前瞻性、随机、双盲对照试验,纳入118例择期体外循环心脏手术患者,随机分为玉米来源HES组和马铃薯来源HES组。
  • 研究液体围术期给药(包括CPB预充)直至术后第二天(POD#2),采用目标导向算法。

主要发现

  • 两组HES输注量相似:玉米-HES组1950 ml [1250-2325],马铃薯-HES组2000 ml [1500-2700],P=0.204。
  • 计算失血量:玉米-HES组504 ml [413-672],马铃薯-HES组530 ml [468-705],P=0.107,组间无差异。
  • 两组血液成分需求无差异,AKI发生率相似(P=0.111),血浆肌酐浓度和肾小球滤过率随时间有变化但变化极小。

临床怎么用

  • 在心脏手术围术期使用平衡四淀粉时,原料来源(玉米或马铃薯)不影响失血和肾功能结局,临床选择无需考虑此因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As 6% hydroxyethyl starch (HES) 130/0.40 or 130/0.42 can originate from different vegetable sources, they might have different clinical effects. The purpose of this prospective, randomized, double-blind controlled trial was to compare two balanced tetrastarch solutions, one maize-derived and one potato-derived, on perioperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). METHODS: We randomly assigned 118 patients undergoing elective cardiac surgery into two groups, to receive either a maize- or a potato-derived HES solution. Study fluids were administered perioperatively (including priming of CPB) until the second postoperative day (POD#2) using a goal directed algorithm. The primary outcome was calculated postoperative blood loss up to POD#2. Secondary outcomes included short-term incidence of acute kidney injury (AKI), and long-term effect (up to one yr) on renal function. RESULTS: Preoperative and intraoperative characteristics of the subjects were similar between groups. Similar volumes of HES were administered (1950 ml [1250-2325] for maize-HES and 2000 ml [1500-2700] for potato-HES; P=0.204). Calculated blood loss (504 ml [413-672] for maize-HES vs 530 ml [468-705] for potato-HES; P=0.107) and the need for blood components were not different between groups. The incidence of AKI was similar in both groups (P=0.111). Plasma creatinine concentration and glomerular filtration rates did vary over time, although changes were minimal. CONCLUSIONS: Under our study conditions, HES 130/0.4 or 130/0.42 raw material did not have a significant influence on perioperative blood loss. Moreover, we did not find any effect of tetrastarch raw material composition on short and long-term renal function. CLINICAL TRIAL REGISTRATION: EudraCT number: 2011-005920-16.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Joosten A, Tircoveanu R, Arend S, et al. Impact of balanced tetrastarch raw material on perioperative blood loss: a randomized double blind controlled trial. Br J Anaesth. 2016. PMID: 28077530. doi:10.1093/bja/aew249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。